The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity
- 31 March 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (7), 2488-2496
- https://doi.org/10.1158/0008-5472.can-10-2820
Abstract
The most widely held explanation for the efficacy of local radiotherapy (RT) is based on direct cytotoxicity to cancer cells through the induction of lethal DNA damage. Recent studies have shown that local ablative radiation of established tumors can lead to increased T-cell priming and T-cell–dependent tumor regression, but the underlying mechanism remains unclear. Here, we describe an essential role for type I IFN in local RT-mediated tumor control. We show that ablative RT increases intratumoral production of IFN-β and, more surprisingly, the antitumor effect of RT is abolished in type I IFN nonresponsive hosts. Furthermore, the major target of RT-induced type I IFN is the hematopoietic compartment. RT drastically enhances the cross-priming capacity of tumor-infiltrating dendritic cells (TIDC) from wild-type mice but not type I IFN receptor–deficient mice. The enhanced cross-priming ability of TIDCs after RT was dependent on autocrine production of type I IFNs. By using adenoviral-mediated expression of IFN-β, we show that delivery of exogenous IFN-β into the tumor tissue in the absence of RT is also sufficient to selectively expand antigen-specific T cells leading to complete tumor regression. Our study reveals that local high-dose RT can trigger production of type I IFN that initiates a cascading innate and adaptive immune attack on the tumor. Cancer Res; 71(7); 2488–96. ©2011 AACR.Keywords
This publication has 30 references indexed in Scilit:
- IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor ActivityPublished by The American Association of Immunologists ,2009
- STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to TherapyPLOS ONE, 2009
- Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine MetabolismCancer Research, 2009
- Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFNThe Journal of Immunology, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor ImmunityCancer Research, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Targeting the Primary Tumor to Generate CTL for the Effective Eradication of Spontaneous MetastasesPublished by The American Association of Immunologists ,2007
- Interferons, immunity and cancer immunoeditingNature Reviews Immunology, 2006
- Complex Modulation of Cell Type-Specific Signaling in Response to Type I InterferonsImmunity, 2006